These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 29211798)

  • 1. LipL21 lipoprotein binding to peptidoglycan enables Leptospira interrogans to escape NOD1 and NOD2 recognition.
    Ratet G; Santecchia I; Fanton d'Andon M; Vernel-Pauillac F; Wheeler R; Lenormand P; Fischer F; Lechat P; Haake DA; Picardeau M; Boneca IG; Werts C
    PLoS Pathog; 2017 Dec; 13(12):e1006725. PubMed ID: 29211798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptospira interrogans outer membrane protein LipL21 is a potent inhibitor of neutrophil myeloperoxidase.
    Vieira ML; Teixeira AF; Pidde G; Ching ATC; Tambourgi DV; Nascimento ALTO; Herwald H
    Virulence; 2018 Jan; 9(1):414-425. PubMed ID: 29235397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escape of TLR5 Recognition by
    Holzapfel M; Bonhomme D; Cagliero J; Vernel-Pauillac F; Fanton d'Andon M; Bortolussi S; Fiette L; Goarant C; Wunder EA; Picardeau M; Ko AI; Werling D; Matsui M; Boneca IG; Werts C
    Front Immunol; 2020; 11():2007. PubMed ID: 32849665
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reconstruction of Leptospira interrogans lipL21 gene and characteristics of its expression product].
    Luo DJ; Hu Y; Dennin RH; Yan J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 36(5):458-64. PubMed ID: 17924464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment and application of ELISAs based on rLipL32/1-LipL21-OmpL1/2 fusion antigen of Leptospira interrogans].
    Qiu XF; Xu HF; Guo ZQ; Wang J; Yan J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 37(6):592-8. PubMed ID: 19084957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nucleotide-binding oligomerization domain 1 during cytokine production by macrophages in response to Mycobacterium tuberculosis infection.
    Lee JY; Hwang EH; Kim DJ; Oh SM; Lee KB; Shin SJ; Park JH
    Immunobiology; 2016 Jan; 221(1):70-5. PubMed ID: 26255090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD1 and NOD2: signaling, host defense, and inflammatory disease.
    Caruso R; Warner N; Inohara N; Núñez G
    Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immunodominant B- and T-cell combined epitopes in outer membrane lipoproteins LipL32 and LipL21 of Leptospira interrogans.
    Lin X; Zhao J; Qian J; Mao Y; Pan J; Li L; Peng H; Luo Y; Yan J
    Clin Vaccine Immunol; 2010 May; 17(5):778-83. PubMed ID: 20237196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and comparative analysis of genes encoding outer membrane proteins LipL21, LipL32 and OmpL1 in epidemic leptospires.
    Zhang XY; Yu Y; He P; Zhang YX; Hu BY; Yang Y; Nie YX; Jiang XG; Zhao GP; Guo XK
    Acta Biochim Biophys Sin (Shanghai); 2005 Oct; 37(10):649-56. PubMed ID: 16215631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins.
    Bonhomme D; Santecchia I; Vernel-Pauillac F; Caroff M; Germon P; Murray G; Adler B; Boneca IG; Werts C
    PLoS Pathog; 2020 Aug; 16(8):e1008639. PubMed ID: 32790743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD1 and NOD2 receptors: integral members of the innate and adaptive immunity system.
    Antosz H; Osiak M
    Acta Biochim Pol; 2013; 60(3):351-60. PubMed ID: 23901396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of monoclonal antibodies against recombinant LipL21 protein of pathogenic Leptospira through phage display technology.
    Mohd Ali MR; Sum JS; Aminuddin Baki NN; Choong YS; Nor Amdan NA; Amran F; Lim TS
    Int J Biol Macromol; 2021 Jan; 168():289-300. PubMed ID: 33310091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune memory through TLR2 and NOD2 contributes to the control of Leptospira interrogans infection.
    Santecchia I; Vernel-Pauillac F; Rasid O; Quintin J; Gomes-Solecki M; Boneca IG; Werts C
    PLoS Pathog; 2019 May; 15(5):e1007811. PubMed ID: 31107928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of human plasminogen by the lipoprotein LipL46 of Leptospira interrogans.
    Santos JV; Pereira PRM; Fernandes LGV; Siqueira GH; de Souza GO; Souza Filho A; Vasconcellos SA; Heinemann MB; Chapola EGB; Nascimento ALTO
    Mol Cell Probes; 2018 Feb; 37():12-21. PubMed ID: 29108931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of the pL40 protein in Leptospira interrogans.
    Zhao W; Chen CY; Zhang XY; Lai WQ; Hu BY; Zhao GP; Qin JH; Guo XK
    Can J Microbiol; 2009 Jun; 55(6):739-49. PubMed ID: 19767845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs.
    Lin X; Xiao G; Luo D; Kong L; Chen X; Sun D; Yan J
    BMC Microbiol; 2016 Oct; 16(1):241. PubMed ID: 27737644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species.
    Cullen PA; Haake DA; Bulach DM; Zuerner RL; Adler B
    Infect Immun; 2003 May; 71(5):2414-21. PubMed ID: 12704111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming problems to produce the recombinant protein LipL21 of
    Takahashi MB; Teixeira AF; Nascimento ALTO
    Biotechniques; 2023 Mar; 74(3):137-142. PubMed ID: 37067289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans.
    Chassin C; Picardeau M; Goujon JM; Bourhy P; Quellard N; Darche S; Badell E; d'Andon MF; Winter N; Lacroix-Lamandé S; Buzoni-Gatel D; Vandewalle A; Werts C
    J Immunol; 2009 Aug; 183(4):2669-77. PubMed ID: 19635914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.